Terry H. Wu

Dr. Terry H. Wu

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2011 in Infection and Immunity
Verified
Journal Article
Closed access
PDF file
GMGopi Mara-Koosham
Gopi Mara-Koosham
JHJulie A. Hutt
Julie A. Hutt
CLC. Rick Lyons
C. Rick Lyons
TWTerry H. Wu
Terry H. Wu
Pneumonic tularemia is a life-threatening disease caused by inhalation of the highly infectious intracellular bacteriumFrancisella tularensis. The most serious form of the disease associated with the type A strains can be prevented in experimental animals through vaccination with the attenuated live vaccine strain (LVS). The protection is largely cell mediated, but the contribution of antibodies remains controversial. We addressed this issue in a series of passive immunization studies in Fischer 344 (F344) rats. Subcutaneous LVS vaccination induced a robust serum antibody response dominated by IgM, IgG2a, and IgG2b antibodies. Prophylactic administration of LVS immune serum or purified immune IgG reduced the severity and duration of disease in naïve rats challenged intratracheally with a lethal dose of the virulent type A strain SCHU S4. The level of resistance increased with the volume of immune serum given, but the maximum survivable SCHU S4 challenge dose was at least 100-fold lower than that shown for LVS-vaccinated rats. Protection correlated with reduced systemic bacterial growth, less severe histopathology in the liver and spleen during the early phase of infection, and bacterial clearance by a T cell-dependent mechanism. Our results suggest that treatment with immune serum limited the sequelae associated with infection, thereby enabling a sterilizing T cell response to develop and resolve the infection. Thus, antibodies induced by LVS vaccination may contribute to the defense of F344 rats against respiratory infection by type A strains ofF. tularensis.

1 July 2009 in Vaccine
Verified
Journal Article
Closed access
TWTerry H. Wu
Terry H. Wu
JZJason L. Zsemlye
Jason L. Zsemlye
GSGloria L. Statom
Gloria L. Statom
JHJulie A. Hutt
Julie A. Hutt
RSRonald M. Schrader
Ronald M. Schrader
CLC. Rick Lyons
C. Rick Lyons

25 May 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RPRoberto De Pascalis
Roberto De Pascalis
AHAndrew Hahn
Andrew Hahn
HBHelen M Brook
Helen M Brook
PRPatrik Ryden
Patrik Ryden
NDNathaniel Donart
Nathaniel Donart
KEKaren L Elkins
Karen L Elkins
There are no defined correlates of protection for any intracellular pathogen, including the bacterium Francisella tularensis, which causes tularemia. Evaluating vaccine efficacy against sporadic diseases like tularemia using field trials is problematic, and therefore alternative strategies to test vaccine candidates like the Francisella Live Vaccine Strain (LVS), such as testing in animals and applying correlate measurements, are needed. Recently, we described a promising correlate strategy that predicted the degree of vaccine-induced protection in mice given parenteral challenges, primarily when using an attenuated Francisella strain. Here, we demonstrate that using peripheral blood lymphocytes (PBLs) in this approach predicts LVS-mediated protection against respiratory challenge of Fischer 344 rats with fully virulent F. tularensis, with exceptional sensitivity and specificity. Rats were vaccinated with a panel of LVS-derived vaccines and subsequently given lethal respiratory challenges with Type A F. tularensis. In parallel, PBLs from vaccinated rats were evaluated for their functional ability to control intramacrophage Francisella growth in in vitro co-culture assays. PBLs recovered from co-cultures were also evaluated for relative gene expression using a large panel of genes identified in murine studies. In vitro control of LVS intramacrophage replication reflected the hierarchy of protection. Further, despite variability between individuals, 22 genes were significantly more up-regulated in PBLs from rats vaccinated with LVS compared to those from rats vaccinated with the variant LVS-R or heat-killed LVS, which were poorly protective. These genes included IFN-γ, IL-21, NOS2, LTA, T-bet, IL-12rβ2, and CCL5. Most importantly, combining quantifications of intramacrophage growth control with 5–7 gene expression levels using multivariate analyses discriminated protected from non-protected individuals with greater than 95% sensitivity and specificity. The results therefore support translation of this approach to non-human primates and people to evaluate new vaccines against Francisella and other intracellular pathogens.

17 August 2022 in npj Vaccines
Verified
Journal Article
Open access
PDF file
RPRoberto De Pascalis
Roberto De Pascalis
BFBlake Frey
Blake Frey
HRHelen M. Rice
Helen M. Rice
VBVarunika Bhargava
Varunika Bhargava
TWTerry H. Wu
Terry H. Wu
KEKaren L. Elkins
Karen L. Elkins
Francisella tularensis, the causative agent of tularemia, is classified as Tier 1 Select Agent with bioterrorism potential. The efficacy of the only available vaccine, LVS, is uncertain and it is not licensed in the U.S. Previously, by using an approach generally applicable to intracellular pathogens, we identified working correlates that predict successful vaccination in rodents. Here, we applied these correlates to evaluate a panel of SchuS4-derived live attenuated vaccines, namely SchuS4-ΔclpB,ΔclpB-ΔfupA,ΔclpB-ΔcapB, andΔclpB-ΔwbtC. We combined in vitro co-cultures to quantify rodent T-cell functions and multivariate regression analyses to predict relative vaccine strength. The predictions were tested by rat vaccination and challenge studies, which demonstrated a clear relationship between the hierarchy of in vitro measurements and in vivo vaccine protection. Thus, these studies demonstrated the potential power a panel of correlates to screen and predict the efficacy ofFrancisellavaccine candidates, and in vivo studies in Fischer 344 rats confirmed that SchuS4-ΔclpBandΔclpB-ΔcapBmay be better vaccine candidates than LVS.

30 April 2020 in Pathogens
Verified
Journal Article
Open access
PDF file
HLHelena Lindgren
Helena Lindgren
KEKjell Eneslätt
Kjell Eneslätt
IGIgor Golovliov
Igor Golovliov
CGCarl Gelhaus
Carl Gelhaus
IRIngrid Rydén
Ingrid Rydén
Anders SjöstedtAnders Sjöstedt
Anders Sjöstedt
Francisella tularensis causes the severe disease tularemia. In the present study, the aim was to identify correlates of protection in the rat co-culture model by investigating the immune responses using two vaccine candidates conferring distinct degrees of protection in rat and mouse models. The immune responses were characterized by use of splenocytes from naïve or Live vaccine strain- (LVS) or ∆clpB/∆wbtC-immunized Fischer 344 rats as effectors and bone marrow-derived macrophages infected with the highly virulent strain SCHU S4. A complex immune response was elicited, resulting in cytokine secretion, nitric oxide production, and efficient control of the intracellular bacterial growth. Addition of LVS-immune splenocytes elicited a significantly better control of bacterial growth than ∆clpB/∆wbtC splenocytes. This mirrored the efficacy of the vaccine candidates in the rat model. Lower levels of IFN-γ, TNF, fractalkine, IL-2, and nitrite were present in the co-cultures with ∆clpB/∆wbtC splenocytes than in those with splenocytes from LVS-immunized rats. Nitric oxide was found to be a correlate of protection, since the levels inversely correlated to the degree of protection and inhibition of nitric oxide production completely reversed the growth inhibition of SCHU S4. Overall, the results demonstrate that the co-culture assay with rat-derived cells is a suitable model to identify correlates of protection against highly virulent strains of F. tularensis

30 June 2011
Verified
Journal Article
Closed access
TWTerry H. Wu
Terry H. Wu
KSKarin Schreiber
Karin Schreiber
AAAinhoa Arina
Ainhoa Arina
NKNikolai N Khodarev
Nikolai N Khodarev
EEElena V Efimova
Elena V Efimova
HSHans Schreiber
Hans Schreiber